Ideas & Impact › Resources › Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe

Using the Cost Effectiveness of Preventing AIDS Complications (CEPAC)—Pediatric model, the study team examined the clinical benefits, costs, and cost-effectiveness of replacing conventional assays for early infant HIV diagnosis with point-of-care (POC) assays at age 6 weeks in Zimbabwe. Compared with conventional assays, POC assays for early infant HIV diagnosis in Zimbabwe were found to improve survival, extend life expectancy of HIV-exposed infants. They are also more cost-effective than conventional assays.

Explore Related Resources

Search More Resources

Resource

Research Review: Pediatric and Maternal HIV at AIDS 2026

Published September 2026

After reviewing the research on pediatric HIV presented at AIDS 2026, here is how we are putting these findings into practice.

Topics:

Adolescents,

Children,

Maternal and Child Health,

Mothers and Infants,

Pediatric HIV,

Research

Countries:

Global

Issue Briefs

Common Ground for Global Health Policy Brief: Adolescent HIV

Published August 2026

This policy brief explains the current landscape of adolescent HIV, with a particular focus on adolescent girls and the barriers they face regarding prevention, diagnosis, and treatment. It also provides recommendations for U.S. policymakers.

Topics:

Adolescents,

Advocacy,

HIV,

Pediatric HIV

Countries:

Global

Poster

From Mortality Review to Mortality Reduction: The Importance of Embedding Routine Pediatric HIV Death Audits in Tanzania

Published August 2026

We assessed the implementation of standardized pediatric mortality audits and associated programmatic responses on mortality trends among CLHIV in Tanzania.

Topics:

Pediatric HIV,

Research

Countries:

Tanzania